Pacira BioSciences' Restructuring Costs rose 484.54% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 1207.02%. This contributed to the annual value of $7.7 million for FY2024, which is 2288.07% up from last year.
Per Pacira BioSciences' latest filing, its Restructuring Costs stood at $6.8 million for Q3 2025, which was up 971.14% from $634,000 recorded in Q2 2025.
Pacira BioSciences' Restructuring Costs' 5-year high stood at $10.9 million during Q4 2022, with a 5-year trough of -$1.8 million in Q3 2024.
Over the past 3 years, Pacira BioSciences' median Restructuring Costs value was $1.9 million (recorded in 2024), while the average stood at $2.2 million.
Its Restructuring Costs has fluctuated over the past 5 years, first plummeted by 983.00% in 2024, then surged by 484.54% in 2025.
MRQ analysis of 4 years shows Pacira BioSciences' Restructuring Costs stood at $10.9 million in 2022, then tumbled by 113.40% to -$1.5 million in 2023, then skyrocketed by 430.60% to $4.8 million in 2024, then skyrocketed by 40.60% to $6.8 million in 2025.
Its last three reported values are $6.8 million in Q3 2025, $634,000 for Q2 2025, and $6.2 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value